Clinical Trials
31 trialsSAA
University of California, Davis
TIMELY-PLEX
Mayo Clinic
A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells
University of Texas Southwestern Medical Center
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
University of Texas Southwestern Medical Center
The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury
University of Alabama at Birmingham
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Alexion Pharmaceuticals, Inc.
Biobank For MS And Other Demyelinating Diseases
Accelerated Cure Project for Multiple Sclerosis
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
University of Alabama at Birmingham
Telex
Burke Medical Research Institute
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
University of Bern
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
KANGUROO
Urovant Sciences GmbH
Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis
Assiut University
SONICS
University of Texas Southwestern Medical Center
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
Q Therapeutics, Inc.
Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Alexion Pharmaceuticals, Inc.
TMCAPTURE
University of Texas Southwestern Medical Center
Ultrasound Imaging Based Sensing of Human Ankle Motion Intent and Control Strategies for Ankle Assistance
North Carolina State University
ISCoPE-TM
St George's, University of London
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
State University of New York at Buffalo
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Alexion Pharmaceuticals, Inc.
Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
Johns Hopkins University
Clinical Trial of a Serious Game for Individuals With SCI/D
University of Michigan
Central Pain Study for ABX-1431
Abide Therapeutics
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
Johns Hopkins University
CHAMPIONS10
Beth Israel Deaconess Medical Center
STRIVE
Guy's and St Thomas' NHS Foundation Trust
Safety and Tolerability of Rituximab in Neuromyelitis Optica
University of California, San Francisco
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Office of Rare Diseases (ORD)